Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta
- PMID: 2492018
Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta
Abstract
Lysosomal neuraminidase from human placenta has been obtained in its active form by association of an inactive neuraminidase polypeptide with beta-galactosidase and the protective protein. Using a specific antiserum, we have now identified a 66-kDa protein as the inactive neuraminidase polypeptide. It is specifically recognized on immunoblots only in its nonreduced state, and it coprecipitates with neuraminidase activity. The 66-kDa polypeptide is substantially glycosylated (38-kDa protein core with 7-14 N-linked oligosaccharide chains), a feature characteristic of lysosomal integral membrane proteins. Specific removal of the 66-kDa neuraminidase polypeptide from glycoprotein preparations prevents the generation of neuraminidase activity. Removal of beta-galactosidase or destruction of the protective protein also hinders the formation of active neuraminidase. Reconstitution of neuraminidase activity is observed after mixing glycoprotein preparations, depleted in different components of the beta-galactosidase-neuraminidase-protective protein complex, indicating that all three components of the complex are required for neuraminidase activity. Association of the neuraminidase polypeptide and the protective protein generates unstable neuraminidase activity, whereas association with beta-galactosidase is required for stability.
Similar articles
-
Purification and partial characterization of lysosomal neuraminidase from human placenta.Eur J Biochem. 1987 Jan 2;162(1):63-7. doi: 10.1111/j.1432-1033.1987.tb10542.x. Eur J Biochem. 1987. PMID: 3102233
-
Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex.Biochem J. 1990 Apr 1;267(1):197-202. doi: 10.1042/bj2670197. Biochem J. 1990. PMID: 2109603 Free PMC article.
-
Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein.Eur J Biochem. 1985 Jun 3;149(2):315-21. doi: 10.1111/j.1432-1033.1985.tb08928.x. Eur J Biochem. 1985. PMID: 3922758
-
Molecular heterogeneity in human beta-galactosidase and neuraminidase deficiency.Enzyme. 1987;38(1-4):132-43. doi: 10.1159/000469199. Enzyme. 1987. PMID: 3126043 Review.
-
Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.Biochim Biophys Acta. 1999 Oct 8;1455(2-3):85-103. doi: 10.1016/s0925-4439(99)00075-7. Biochim Biophys Acta. 1999. PMID: 10571006 Review.
Cited by
-
Some questions and suggestions on the type references of the official nomenclature (IUB) for sialidase(s) and endosialidase.Biochem J. 1991 Aug 15;278 ( Pt 1)(Pt 1):311-2. doi: 10.1042/bj2780311. Biochem J. 1991. PMID: 1883340 Free PMC article. No abstract available.
-
Structure of the immunoregulatory sialidase NEU1.Sci Adv. 2023 May 19;9(20):eadf8169. doi: 10.1126/sciadv.adf8169. Epub 2023 May 19. Sci Adv. 2023. PMID: 37205763 Free PMC article.
-
Structure of the murine lysosomal multienzyme complex core.Sci Adv. 2021 May 12;7(20):eabf4155. doi: 10.1126/sciadv.abf4155. Print 2021 May. Sci Adv. 2021. PMID: 33980489 Free PMC article.
-
Sialidase and malignancy: a minireview.Glycoconj J. 2004;20(3):189-98. doi: 10.1023/B:GLYC.0000024250.48506.bf. Glycoconj J. 2004. PMID: 15090732 Review.
-
Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells.Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):281-8. doi: 10.1042/bj3040281. Biochem J. 1994. PMID: 7998946 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources